rofecoxib has been researched along with Kaposi Sarcoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coras, B | 1 |
| Hafner, C | 1 |
| Reichle, A | 1 |
| Hohenleutner, U | 1 |
| Szeimies, RM | 1 |
| Landthaler, M | 1 |
| Vogt, T | 1 |
1 other study available for rofecoxib and Kaposi Sarcoma
| Article | Year |
|---|---|
Antiangiogenic therapy with pioglitazone, rofecoxib, and trofosfamide in a patient with endemic kaposi sarcoma.
Topics: Adult; Angiogenesis Inhibitors; Cyclophosphamide; Drug Therapy, Combination; Endemic Diseases; Human | 2004 |